Publication Details
Abstract
The article presents the results of the analysis of drugs with antihelmintic properties in the domestic pharmaceutical market. The object of research was the State Register of drugs, medical equipment and medical equipment approved for use in medical practice in the Republic of Uzbekistan. As a result of the analysis, the total number of registered drugs of this pharmacotherapeutic group was calculated, and conclusions were drawn on the share of producing countries, the form of the drug, and the nature of the active substance. Based on the results of the research, among the antihelmintic drugs registered in the Republic of Uzbekistan, the first place in terms of share is taken by the drugs produced in Uzbekistan, the second place by the drugs of foreign countries, and the third place by the drugs of the CIS countries. It was found that the average share of herbal medicines in the analyzed period among all mentioned medicines is 17.2%, the share of synthetic drugs is 76.2%, and the share of combined drugs is 6.6%. According to the form of the drug, it was found that antihelminth drugs are mainly produced in the form of a solid drug that is easy to drink and stable in storage. However, from 2019 to 2023, the share of drugs derived from plant raw materials and belonging to this pharmacotherapeutic group will decrease and the number of synthetic drugs will increase. Taking into account a number of side effects of synthetic drugs, the production and introduction of effective, stable and high-quality drugs with antihelmintic properties based on local plant raw materials has been proved to be relevant.